Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Multiple epiphyseal dysplasia (MED) is a rare genetic skeletal disorder that primarily affects the development of bone and cartilage in the ends of the long bones (epiphyses), often leading to joint pain and early-onset osteoarthritis. While severity varies significantly between individuals, it is typically characterized by shortened stature and limited range of motion in the hips, knees, and ankles. What is Multiple epiphyseal dysplasia? Multiple epiphyseal dysplasia is a disorder of bone growth that specifically targets the epiphyses, which are the rounded ends of long bones where growth occurs during childhood.
TL;DR: Multiple epiphyseal dysplasia (MED) is a rare genetic skeletal disorder that primarily affects the development of bone and cartilage in the ends of the long bones (epiphyses), often leading to joint pain and early-onset osteoarthritis. While severity varies significantly between individuals, it is typically characterized by shortened stature and limited range of motion in the hips, knees, and ankles.
Multiple epiphyseal dysplasia is a disorder of bone growth that specifically targets the epiphyses, which are the rounded ends of long bones where growth occurs during childhood. In individuals with Multiple epiphyseal dysplasia, these areas do not ossify (turn to bone) properly, resulting in irregular, flattened, or fragmented bone ends. This structural variation interferes with smooth joint movement, which is why chronic joint pain and stiffness are the most common clinical presentations for those living with the condition.
The primary system affected is the skeletal system. Because the condition involves the cartilage-to-bone transformation process, the joints are the most frequent sites of symptoms. Common clinical manifestations include:
Multiple epiphyseal dysplasia is genetically heterogeneous, meaning it can be caused by mutations in several different genes. These classifications are often grouped by the mode of inheritance and the specific gene involved, such as COMP, COL9A1, COL9A2, COL9A3, MATN3, or DTDST. Clinically, it is often categorized into two main types based on the X-ray appearance of the bones: the "mild" (Ribbing) type and the "severe" (Fairbank) type, though these labels are broad generalizations.
While the exact global prevalence is unknown, Multiple epiphyseal dysplasia is estimated to occur in approximately 1 in 10,000 to 1 in 20,000 individuals. Because symptoms can be mild in some people, it is likely underdiagnosed. At DiseaseMaps.org, we currently have 89 community members who have been diagnosed with Multiple epiphyseal dysplasia, highlighting the importance of shared experiences in managing this rare condition.
It is often confused with other skeletal dysplasias, such as pseudoachondroplasia. However, Multiple epiphyseal dysplasia is distinct because it typically spares the vertebrae and skull, whereas other dysplasias often involve more widespread spinal involvement or severe dwarfism. Genetic testing is the gold standard for differentiating Multiple epiphyseal dysplasia from other forms of osteochondrodysplasia.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.